(0.02%) 5 071.63 points
(-0.11%) 38 461 points
(0.10%) 15 713 points
(-0.19%) $82.65
(0.91%) $1.668
(-0.41%) $2 328.80
(-0.48%) $27.22
(-0.47%) $911.50
(0.00%) $0.935
(0.07%) $10.99
(0.03%) $0.803
(0.00%) $92.32
Live Chart Being Loaded With Signals
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses...
Stats | |
---|---|
Today's Volume | 34 720.00 |
Average Volume | 37 895.00 |
Market Cap | 22.12B |
EPS | $54.47 ( 2023-09-30 ) |
Last Dividend | $0.205 ( 2021-12-29 ) |
Next Dividend | $0 ( N/A ) |
P/E | 28.31 |
ATR14 | $0.0110 (0.05%) |
Volume Correlation
Otsuka Holdings Co., Ltd. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Otsuka Holdings Co., Ltd. Correlation - Currency/Commodity
Otsuka Holdings Co., Ltd. Financials
Annual | 2023 |
Revenue: | $2 018.57B |
Gross Profit: | $1 407.35B (69.72 %) |
EPS: | $224.11 |
Q4 | 2023 |
Revenue: | $539.49B |
Gross Profit: | $373.62B (69.26 %) |
EPS: | $-73.89 |
Q3 | 2023 |
Revenue: | $531.54B |
Gross Profit: | $374.05B (70.37 %) |
EPS: | $108.94 |
Q2 | 2023 |
Revenue: | $499.19B |
Gross Profit: | $348.11B (69.73 %) |
EPS: | $75.85 |
Financial Reports:
No articles found.
Otsuka Holdings Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.226 | 2020-12-29 |
Last Dividend | $0.205 | 2021-12-29 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $0.657 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.46 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.99 | |
Div. Directional Score | 8.10 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TEZNY | Ex Dividend Junior | 2023-06-16 | Semi-Annually | 0 | 0.00% | |
IBDRY | Ex Dividend Knight | 2023-07-07 | Semi-Annually | 0 | 0.00% | |
BICEY | Ex Dividend Knight | 2023-05-24 | Annually | 0 | 0.00% | |
PGENY | Ex Dividend Knight | 2023-06-29 | Annually | 0 | 0.00% | |
ELEZY | Ex Dividend Knight | 2023-06-29 | Annually | 0 | 0.00% | |
UCBJY | Ex Dividend Knight | 2023-05-01 | Annually | 0 | 0.00% | |
KAJMF | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
CCOEF | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
RSTRF | Ex Dividend Knight | 2023-09-19 | Semi-Annually | 0 | 0.00% | |
FMFP | Ex Dividend Junior | 2023-09-14 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0602 | 1.500 | 8.80 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0362 | 1.200 | 8.79 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0508 | 1.500 | -0.547 | -0.821 | [0.1 - 1] |
payoutRatioTTM | 0.458 | -1.000 | 5.42 | -5.42 | [0 - 1] |
currentRatioTTM | 1.989 | 0.800 | 5.06 | 4.05 | [1 - 3] |
quickRatioTTM | 1.533 | 0.800 | 5.69 | 4.55 | [0.8 - 2.5] |
cashRatioTTM | 0.769 | 1.500 | 6.84 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0468 | -1.500 | 9.22 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 37.62 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 521.91 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 310.60 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0658 | -1.500 | 9.74 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.697 | 1.000 | 1.713 | 1.713 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.126 | 1.000 | 9.49 | 9.49 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.799 | 1.000 | 1.119 | 1.119 | [0.2 - 2] |
assetTurnoverTTM | 0.601 | 0.800 | 9.33 | 7.46 | [0.5 - 2] |
Total Score | 11.20 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 14.22 | 1.000 | 8.66 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0508 | 2.50 | -0.352 | -0.821 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 310.60 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.00854 | 1.500 | 9.79 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 521.91 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.458 | 1.500 | 5.42 | -5.42 | [0 - 1] |
pegRatioTTM | 0.00267 | 1.500 | -3.32 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.140 | 1.000 | 8.99 | 0 | [0.1 - 0.5] |
Total Score | 4.99 |
Otsuka Holdings Co., Ltd.
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a drinkable-liquid; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a household antiseptic medicine. In addition, the company offers soft drinks, food products, and wines; chemicals; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; hydrazine; insecticide and toiletry products; and adhesive tapes. Further, it operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators